KIT and neoplasm: The clinicopathological parameters between two groups were compared in Table 1, which showed significant difference in rupture status (P < 0.001), resection style (P = 0.001), tumor site (P = 0.025), tumor size (P < 0.001), mitotic index (P < 0.001), NIH risk grade (P < 0.001) and c-kit exons (P = 0.001).